Acquired pure red cell aplasia
From Wikipedia, the free encyclopedia
Acquired pure red cell aplasia Classification and external resources |
|
ICD-10 | D60. |
---|---|
ICD-9 | 284.8 |
DiseasesDB | 29063 |
eMedicine | med/1967 |
MeSH | D012010 |
Acquired pure red cell aplasia (or PRCA) refers to a type of anemia affecting the precursors to red blood cells but not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells.
Contents |
[edit] Causes
Pure red cell aplasia is regarded as an autoimmune disease. It may also be a manifestation of thymoma. It may also be as a result of viral infections such as HIV, herpes, parvovirus B19 (Fifth disease), or hepatitis. Association of pure red cell aplasia with T large granular lymphocyte leukemia is also well recognized, especially in China.[1] Many cases of PRCA are considered idiopathic in that there is no discernible cause detected.
It can be associated with the administration of erythropoietin.[2]
[edit] Treatment
PRCA is considered an autoimmune disease as it will respond to immunosuppressant treatment such as ciclosporin. It has also been shown to respond to treatments with Rituxan.
[edit] See also
- Diamond-Blackfan anemia (genetic red cell aplasia)
- aplastic anemia (aplasia affecting other bone marrow cells as well)
[edit] References
- ^ Association of pure red cell aplasia with T large granular lymphocyte leukaemia -- Kwong and Wong 51 (9): 672 -- Journal of Clinical Pathology. Retrieved on 2007-11-07.
- ^ Bennett CL, Luminari S, Nissenson AR, et al (2004). "Pure red-cell aplasia and epoetin therapy". N. Engl. J. Med. 351 (14): 1403–8. doi: . PMID 15459301.